Sep 10, 2024 Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders We are pleased to announce three new UK DRI Emerging Leaders: Dr Maura Malpetti, Dr... Learn more Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
News Jul 31, 2025 - Research Human data mining can transform our search for neurodegeneration treatments Human data mining – the systematic analysis of large-scale health databases - is already transforming... Learn more Human data mining can transform our search for neurodegeneration treatments Jul 30, 2025 - Update Dementia Trials Accelerator partners with REACT and Inuvi to streamline recruitment for dementia clinical trials The Dementia Trials Accelerator, an initiative led by the UK DRI and HDR UK, joins... Learn more Dementia Trials Accelerator partners with REACT and Inuvi to streamline recruitment for dementia clinical trials Jul 29, 2025 - Comment Results from trontinemab Phase II trial presented at AAIC conference Results from Roche's Phase Ib/IIa trial of new Alzheimer's drug trontinemab were presented at the... Learn more Results from trontinemab Phase II trial presented at AAIC conference
Jul 31, 2025 - Research Human data mining can transform our search for neurodegeneration treatments Human data mining – the systematic analysis of large-scale health databases - is already transforming... Learn more Human data mining can transform our search for neurodegeneration treatments
Jul 30, 2025 - Update Dementia Trials Accelerator partners with REACT and Inuvi to streamline recruitment for dementia clinical trials The Dementia Trials Accelerator, an initiative led by the UK DRI and HDR UK, joins... Learn more Dementia Trials Accelerator partners with REACT and Inuvi to streamline recruitment for dementia clinical trials
Jul 29, 2025 - Comment Results from trontinemab Phase II trial presented at AAIC conference Results from Roche's Phase Ib/IIa trial of new Alzheimer's drug trontinemab were presented at the... Learn more Results from trontinemab Phase II trial presented at AAIC conference
